Tag: FTC pharmaceutical competition
Patent Litigation: How Authorized Generics Undermine Generic Competition
Nov, 27 2025
Authorized generics let brand drug makers launch their own cheaper versions right when independent generics enter the market, undermining price competition and reducing incentives for patent challenges. This practice hurts patients and generic manufacturers - and regulators are fighting back.
Read Article→
online pharmacy
generic drugs
side effects
medication safety
dosage
counterfeit drugs
Hatch-Waxman Act
medication side effects
generic substitution
medication adherence
benefits
pharmacy alternatives
alternatives
family support
Parkinson's disease
motor symptoms
blood sugar control
warfarin
chronic kidney disease
anticoagulant safety